Interleukin-1 mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo

Blood

Volumn 112, Issue 13, 2008, Pages 4895-4904

  Orelio, Claudia ^a   Haak, Esther ^a   Peeters, Marian ^a   Dzierzak, Elaine ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO (ANATOMY); ENDOTHELIUM CELL; FEMALE; GONAD; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; MALE; MESENCHYME CELL; MESONEPHROS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PROTECTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; CELL LINEAGE; CYTOLOGY; PHYSIOLOGY;

ANIMALS; AORTA; CELL LINEAGE; EMBRYO, MAMMALIAN; GONADS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-1; MESONEPHROS; MICE; MYELOID CELLS; RECEPTORS, INTERLEUKIN-1;

EID: 58149398633     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-123836     Document Type: Article

References (51)

1. Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood. 1993;81:2579-2584.
2. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
3. Fibbe WE, Goselink HM, Van Eeden G, et al. Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood. 1988;72:1242-1247.
4. Heimfeld S, Hudak S, Weissman I, Rennick D. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci USA. 1991;88:9902-9906.
5. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. Astem cell molecular signature. Science. 2002;298:601-604.
6. McKinstry WJ, Li CL, Rasko JE, Nicola NA, Johnson GR, Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood. 1997;89:65-71.
7. Watari K, Mayani H, Lee F, Dragowska W, Lansdorp PM, Schrader JW. Production of inter-leukin 1beta by human hematopoietic progenitor cells. J Clin Invest. 1996;97:1666-1674.
8. Neta R, Douches S, Oppenheim JJ. Interleukin 1 is a radioprotector. J Immunol. 1986;136:2483-2485.
9. Oppenheim JJ, Neta R, Tiberghien P, Gress R, Kenny JJ, Longo DL. Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells. Blood. 1989;74:2257-2263.
10. Zucali JR, Moreb J, Gibbons W, et al. Radiopro-tection of hematopoietic stem cells by interleukin-1. Exp Hematol. 1994;22:130-135.
11. Dalmau SR, Freitas CS, Savino W. Radio- and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines. Leuk Res. 1997;21:93-99.
12. Eastgate J, Moreb J, Nick HS, Suzuki K, Taniguchi N, Zucali JR. A role for manganese superoxide dis-mutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood. 1993;81:639-646.
13. Fibbe WE, Hamilton MS, Laterveer LL, et al. Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. J Immunol. 1992;148:417-421.
14. Voermans C, Rood PM, Hordijk PL, Gerritsen WR, van der Schoot CE. Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells. Stem Cells. 2000;18:435-443.
15. Eddleston J, Christiansen SC, Zuraw BL. Functional expression of the C-X-C chemokine receptor CXCR4 by human bronchial epithelial cells: regulation by pro-inflammatory mediators. J Immunol. 2002;169:6445.
16. Fedyk ER, Jones D, Critchley HOD, Phipps RP, Blieden TM, Springer TA. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF in dermal wound healing. J Immunol. 2001;166:5749.
17. Gurjar MV, Deleon J, Sharma RV, Bhalla RC. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am J Physiol Heart Circ Physiol. 2001;281:H2568-H2574.
18. Upchurch GR Jr, Ford JW, Weiss SJ, et al. Nitric oxide inhibition increases matrix metalloprotein-ase-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg. 2001;34:76-83.
19. Neta R, Perlstein R, Vogel SN, Ledney GD, Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med. 1992;175:689-694.
20. North TE, Goessling W, Walkley CR, et al. Prosta-glandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007;447:1007-1011.
21. Jacobsen SE, Ruscetti FW, Okkenhaug C, et al. Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro. Exp Hematol. 1994;22:1064-1069.
22. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A. 1996;93:4040-4044.
23. Palis J, Yoder MC. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol. 2001;29:927-936.
24. Alvarez-Silva M, Belo-Diabangouaya P, Salaun J, Dieterlen-Lievre F. Mouse placenta is a major hema-topoietic organ. Development. 2003;130:5437-5444.
25. Cumano A, Ferraz JC, Klaine M, Di Santo JP, Godin I. Intraembryonic, but not yolk sac hemato-poietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity. 2001;15:477-485.
26. Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity. 1997;7:335-344.
27. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez M-J, Dzierzak E. Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity. 2002;16:673-683.
28. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996;86:897-906.
29. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK. The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005;8:365-375.
30. Kumaravelu P, Hook L, Morrison AM, et al. Quantitative developmental anatomy of definitive he-matopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-meso-nephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development. 2002;129:4891-4899.
31. Muller AM, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity. 1994;1:291-301.
32. Ottersbach K, Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell. 2005;8:377.
33. Orelio C, Dzierzak E. Identification of 2 novel genes developmentally regulated in the mouse aorta-gonad-mesonephros region. Blood. 2003;101:2246-2249.
34. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 2003;22:6277-6288.
35. Takaesu G, Ninomiya-Tsuji J, Kishida S, Li X, Stark GR, Matsumoto K. Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol Cell Biol. 2001;21:2475-2484.
36. Strouboulis J, Dillon N, Grosveld F. Developmental regulation of a complete 70 kb human beta-globin locus in transgenic mice. Genes Dev. 1992;6:1857-1864.
37. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
38. Glaccum MB, Stocking KL, Charrier K, et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol. 1997;159:3364-3371.
39. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 2000;19:2465-2474.
40. Oostendorp RAJ, Robin C, Steinhoff C, et al. Long-term maintenance of hematopoietic stem cells does not require contact with embryo-derived stromal cells in co-cultures. Stem Cells. 2005;23:842.
41. Glaccum MB, Stocking KL, Charrier K, et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol. 1997;159:3364-3371.
42. Horai R, Asano M, Sudo K, et al. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med. 1998;187:1463-1475.
43. Greten FR, Arkan MC, Bollrath J, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007;130:918-931.
44. Hestdal K, Jacobsen SE, Ruscetti FW, et al. In vivo effect of interleukin-1 alpha on hematopoi-esis: role of colony-stimulating factor receptor modulation. Blood. 1992;80:2486-2494.
45. Ido M, Harada M, Furuichi H, Matsuoka N, Nakano K, Sohmura Y. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice. Exp Hematol. 1992;20:161-166.
46. Jonsson JI, Nilsson K, Phillips RA. Concentration-dependent effects of hematopoietic growth factors during in vitro expansion of mouse stem cells and progenitor cells. Growth Factors. 1997;14:59-66.
47. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N YAcad Sci. 1998;856:1-11.
48. Gillespie MT, Horwood NJ. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 1998;9:109.
49. Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest. 1989;83:444-455.
50. Mackay AR, Ballin M, Pelina MD, et al. Effect of phorbol ester and cytokines on matrix metallopro-teinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis. 1992;12:168-184.
51. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoi-etic stem cells require stromal cell-derived fac-tor-1 for colonizing bone marrow during ontogeny. Immunity. 2003;19:257-267.